SEC Form 4 · accession 0000950138-16-001186
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian J Watkins
Officer — Sr. VP & Chief HR Officer · Director
Period of report
Jul 1, 2016
Accepted (ET)
Jul 6, 2016 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jul 1, 2016 | F | 910 | $61.84 | D | 15,942 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 221 shares acquired between January 7, 2016 and June 6, 2016 under the Mallinckrodt employee stock purchase plan.
Remarks
This Form 4 constitutes a notice for purposes of Part V of the Companies Act 2014.